Viewing Study NCT06999434


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-26 @ 6:54 PM
Study NCT ID: NCT06999434
Status: RECRUITING
Last Update Posted: 2025-05-31
First Post: 2025-05-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Exploring the Utility of [18F]3F4AP for Demyelination Imaging
Sponsor: Yale University
Organization:

Study Overview

Official Title: Exploring the Utility of [18F]3F4AP for Demyelination Imaging
Status: RECRUITING
Status Verified Date: 2025-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The overall objective is to obtain an assessment of the pharmacokinetics of \[18F\]3F4AP in healthy volunteers and subjects with demyelinating diseases such as mild cognitive impairment (MCI), Alzheimer's Disease (AD), Multiple Sclerosis (MS), Spinal Cord Injury (SCI) and Spinal radiculopathy (SR).
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
7P41EB022544-08 NIH None https://reporter.nih.gov/quic… View
7R01EB033582-03 NIH None https://reporter.nih.gov/quic… View
7R01AG076153-03 NIH None https://reporter.nih.gov/quic… View
1R01AG085561-01 NIH None https://reporter.nih.gov/quic… View